Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,955 | -41,658 | -31,846 | -35,038 | -22,051 |
| Depreciation Amortization | 383 | 1,555 | 1,171 | 783 | 417 |
| Income taxes - deferred | 8 | 28 | 20 | 15 | 9 |
| Accounts receivable | N/A | 1,060 | 1,060 | 516 | 123 |
| Accounts payable and accrued liabilities | 2,683 | -487 | -1,922 | -1,205 | 388 |
| Other Working Capital | -1,523 | 4,770 | 133 | -1,277 | 246 |
| Other Operating Activity | -1,648 | 7,981 | 8,573 | 7,669 | 4,801 |
| Operating Cash Flow | $-10,052 | $-26,751 | $-22,811 | $-28,537 | $-16,067 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 25 | -95 | -95 | -56 | N/A |
| Other Investing Activity | -158 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-133 | $-95 | $-95 | $-56 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -14,806 | -14,806 | N/A |
| Common Stock Issued | 13,748 | -14,699 | 25 | 25 | N/A |
| Financing Cash Flow | $13,748 | $-14,699 | $-14,781 | $-14,781 | $N/A |
| Beginning Cash Position | 13,318 | 54,863 | 54,864 | 54,864 | 54,863 |
| End Cash Position | 16,881 | 13,318 | 17,177 | 11,490 | 38,796 |
| Net Cash Flow | $3,563 | $-41,545 | $-37,687 | $-43,374 | $-16,067 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,052 | -26,751 | -22,811 | -28,537 | -16,067 |
| Capital Expenditure | N/A | -95 | -95 | -56 | N/A |
| Free Cash Flow | -10,052 | -26,846 | -22,906 | -28,593 | -16,067 |